HGH (ProBLEN)


Welcome to the PulseAid listing for the HGH drug offered from ProBLEN. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: ProBLEN
NON-PROPRIETARY NAME: HGH, Hepar Bovinum, Pituitary Bovinum
SUBSTANCE NAME: SOMATROPIN; BEEF LIVER; BOS TAURUS PITUITARY GLAND
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2013-03-06
END MARKETING DATE: 2020-11-10


HGH HUMAN OTC DRUG Details:

Item DescriptionHGH from ProBLEN
LABELER NAME: ProBLEN
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 6; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2013-03-06
END MARKETING DATE: 2020-11-10
PRODUCT ID: 43853-0007_ddfc5ce5-5954-4f9f-a703-adcc1090ecdf
PRODUCT NDC: 43853-0007
APPLICATION NUMBER:

Other SOMATROPIN; BEEF LIVER; BOS TAURUS PITUITARY GLAND Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Liddell Laboratories, Inc.ProBlen HGH
ProBLENHGH